| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 2,417 | 1,587 | 756 | | Cost of Revenue | 1,432 | 1,348 | 954 | | | Gross Profit | 986 | 238 | (198) | | | Operating Expenses | | Research Development | 12,316 | 13,118 | 8,384 | | Selling General and Administrative | 11,600 | 12,135 | 10,054 | | Non Recurring |
-
|
-
|
-
| | Others | 790 | 790 | 673 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (23,720) | (25,804) | (19,309) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 102 | 482 | 716 | | Earnings Before Interest And Taxes | (23,617) | (25,322) | (18,593) | | Interest Expense | 981 |
-
|
-
| | Income Before Tax | (24,598) | (25,322) | (18,593) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (24,598) | (25,322) | (18,593) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (24,598) | (25,322) | (18,593) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($24,598) | ($25,322) | ($18,593) |
|
0.47% Nasdaq 0.00%
Income Statement
